Fulgent Genetics Inc (FLGT)
Operating profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | -73,918 | -72,695 | 178,527 | 104,339 | 290,158 |
| Revenue | US$ in thousands | 283,470 | 289,213 | 618,968 | 992,584 | 421,712 |
| Operating profit margin | -26.08% | -25.14% | 28.84% | 10.51% | 68.80% |
December 31, 2024 calculation
Operating profit margin = Operating income ÷ Revenue
= $-73,918K ÷ $283,470K
= -26.08%
The operating profit margin of Fulgent Genetics Inc has shown significant fluctuations over the years. In December 31, 2020, the operating profit margin was robust at 68.80%, indicating the company was able to generate substantial profits from its core operations. However, there was a sharp decline in profitability by December 31, 2021, with the operating profit margin dropping to 10.51%. This could suggest challenges faced by the company in controlling costs or maintaining revenue streams.
By December 31, 2022, the operating profit margin improved to 28.84%, indicating a recovery in the company's operational efficiency. Nonetheless, the profitability trend reversed in the following years. The operating profit margin plummeted to -25.14% by December 31, 2023, and further declined to -26.08% by December 31, 2024. These negative margins indicate that the company's operating expenses exceeded its gross profit, resulting in operating losses.
Overall, Fulgent Genetics Inc's operating profit margin has been volatile, with both highs and lows observed in the past few years. It is essential for the company to closely monitor and manage its operating costs, sales pricing, and overall operational efficiency to improve its profitability outlook in the future.
Peer comparison
Dec 31, 2024